GSA Capital Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Sell	11,828 -20,094	-63%	-$646K	0.02%	1086
2025 Q4	$1.12M	Buy	31,922 +16,237	+104%	+$575K	0.1%	301
2025 Q3	$412K	Sell	15,685 -5,598	-26%	-$167K	0.03%	983
2025 Q2	$564K	Buy	+21,283	New	+$560K	0.04%	837
2025 Q1	–	Sell	-5,522	Closed	-$222K	–	2106
2024 Q4	$222K	Sell	5,522 -2,638	-32%	-$150K	0.02%	1367
2024 Q3	$517K	Buy	8,160 +3,202	+65%	+$188K	0.04%	878
2024 Q2	$263K	Buy	+4,958	New	+$325K	0.02%	1341
2024 Q1	–	Sell	-68,415	Closed	-$1.27M	–	1994
2023 Q4	$1.27M	Sell	68,415 -21,326	-24%	-$279K	0.11%	278
2023 Q3	$993K	Buy	89,741 +29,319	+49%	+$419K	0.09%	401
2023 Q2	$979K	Sell	60,422 -55,618	-48%	-$1.17M	0.1%	325
2023 Q1	$1.93M	Sell	116,040 -99,611	-46%	-$1.03M	0.19%	79
2022 Q4	$2.03M	Sell	215,651 -5,832	-3%	-$26K	0.25%	27
2022 Q3	$602K	Buy	221,483 +54,127	+32%	+$177K	0.08%	441
2022 Q2	$484K	Buy	167,356 +27,692	+20%	+$68.5K	0.07%	525
2022 Q1	$419K	Buy	139,664 +62,964	+82%	+$226K	0.06%	658
2021 Q4	$353K	Buy	76,700 +23,122	+43%	+$130K	0.04%	826
2021 Q3	$336K	Buy	53,578 +19,618	+58%	+$121K	0.03%	945
2021 Q2	$203K	Sell	33,960 -25,681	-43%	-$152K	0.02%	1179
2021 Q1	$377K	Sell	59,641 -13,458	-18%	-$94.7K	0.06%	511
2020 Q4	$412K	Buy	73,099 +62,198	+571%	+$377K	0.07%	546
2020 Q3	$63K	Buy	+10,901	New	+$75.1K	0.01%	1174
2019 Q1	–	Sell	-13,507	Closed	-$103K	–	1715
2018 Q4	$103K	Sell	13,507 -7,593	-36%	-$90.8K	0.01%	1217
2018 Q3	$368K	Sell	21,100 -35,200	-63%	-$419K	0.02%	1229
2018 Q2	$534K	Buy	+56,300	New	+$374K	0.03%	1127